Stroke thrombolysis in patients taking dabigatran

Internal Medicine Journal

Volumn 43, Issue 7, 2013, Pages 826-828

  Jayathissa, S ^a   Gommans, J ^b   Harper, P ^c  

^a HUTT HOSPITAL   (New Zealand)

^b HAWKE S BAY HOSPITAL   (New Zealand)

^c Midcentral Health ^*  (New Zealand)

Author keywords

Atrial fibrillation; Dabigatran; Stroke; Thrombin time; Thrombolytic therapy

Indexed keywords

CREATININE; DABIGATRAN; WARFARIN;

ADULT; AGED; APHASIA; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; BLOOD CLOTTING TEST; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CREATININE CLEARANCE; DRUG BLOOD LEVEL; FEMALE; HEMATOMA; HEMIPLEGIA; HUMAN; INTERNATIONAL NORMALIZED RATIO; KIDNEY FUNCTION; MALE; PARTIAL THROMBOPLASTIN TIME; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; THROMBIN TIME; VENOUS THROMBOEMBOLISM;

ATRIAL FIBRILLATION; DABIGATRAN; STROKE; THROMBIN TIME; THROMBOLYTIC THERAPY;

AGED; ANIMALS; ANTITHROMBINS; BENZIMIDAZOLES; BETA-ALANINE; HUMANS; MALE; STROKE; THROMBIN TIME; THROMBOLYTIC THERAPY;

EID: 84880336212     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/imj.12182     Document Type: Article

References (15)

1. National stroke audit acute services clinical audit report. [cited 2012 Aug 15]. Available from URL: http://strokefoundation.com.au
2. del Zoppo GJ, Saver JL, Jauch EC, Adams HP Jr, American Heart Association Stroke Council. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke 2009; 40: 2945-2948.
3. Xian Y, Li L, Smith EE, Schwamm LS, Reeves MJ, Olson DM etal. Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator. JAMA 2012; 307: 2600-2608.
4. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A etal. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361: 1139-1151.
5. Alberts MJ, Bernstein RA, Naccarelli GV, Garcia DA. Response to letters regarding article, 'using dabigatran in patients with stroke: a practical guide for clinicians'. Stroke 2012; 43: e49.
6. Dabigatran etexilate (Pradaxa). Boehringer Ingelheim (NZ) Ltd Medsafe data sheet. [cited 2012 Aug 15]. Available from URL: http://www.medsafe.govt.nz
7. Huisman M, Lip GYH, Diene HC, Brueckman M, van Ryn MJ, Clemens A. Dabigatran etexilate for stroke prevention in patients with atrial fibrillation: resolving uncertainties in routine practice. Thromb Haemost 2012; 107: 838-847.
8. van Ryn J, Stangier J, Haertter S, Liesenfeld K, Wienen W, Feuring M etal. Dabigatran etexilate - a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity. Thromb Haemost 2010; 103: 1116-1127.
9. Pfeilschifter W, Bohmann F, Baumgarten P, Mittelbronn M, Pfeilschifter J, Lindhoff-Last E etal. Thrombolysis with recombinant tissue plasminogen activator under dabigatran anticoagulation in experimental stroke. Ann Neurol 2012; 71: 624-633.
10. Lee VH, Conners JJ, Prabhakaran S. Intravenous thrombolysis in a stroke patient taking dabigatran. J Stroke Cerebrovasc Dis 2012; 21: 916.e11-2.
11. Matute AC, Guillán M, Garcia-Caldentey J etal. Thrombolysis treatment for acute ischaemic stroke in a patient on treatment with dabigatran. Thromb Haemost 2011; 106: 178-179.
12. De Smedt A, De Raedt S, Nieboer K, De Keyser J, Brouns R. Intravenous thrombolysis with recombinant tissue plasminogen activator in a stroke patient treated with dabigatran. Cerebrovasc Dis 2010; 30: 533-534.
13. Naranjo IC, Portilla-Cuenca JC, Jiménez Caballero PE, Escobar MLC, Sevilla RMR. Fatal intracerebral hemorrhage associated with administration of recombinant tissue plasminogen activator in a stroke patient on treatment with dabigatran. Cerebrovasc Dis 2011; 32: 614-615.
14. Moey AW, Koblar SA, Chryssidis S, Robinson M, Jannes J. Endovascular therapy after stroke in a patient treated with dabigatran. Med J Aust 2012; 196: 469-471.
15. Freeman WD, Kuo RS, Hanel RA. Letter by Freeman etal. regarding article, using dabigatran in patients with stroke: a practical guide for clinicians. Stroke 2012; 43: e48 (author reply e49).